Keywords: new, fragment-based, drug, discovery, center, evotec, germany

New fragment-based drug discovery center for Evotec

Article | 28 May 2007

Print This

Germany's Evotec AG has launched its Innovation Center for Fragment Based Drug Discovery (FBDD), which it says offers an alternative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in